NCT01283048 2016-09-21Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell CarcinomaDana-Farber Cancer InstitutePhase 1 Completed32 enrolled
NCT00421512 2008-11-11A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsMemorial Sloan Kettering Cancer CenterPhase 1 Completed28 enrolled